<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <ref-type name="Thesis">32</ref-type>
  <contributors>
    <authors>
      <author>Koch, Antje</author>
      <author>Mann, Helmut</author>
    </authors>
    <subsidiary-authors>
      <author>510000-1</author>
    </subsidiary-authors>
  </contributors>
  <titles>
    <title>Zum Einfluß von Dialysemembranmaterialien auf den [beta]-2-Mikroglobulinspiegel unter Hämodialyse</title>
  </titles>
  <periodical/>
  <publisher>Publikationsserver der RWTH Aachen University</publisher>
  <pub-location>Aachen</pub-location>
  <language>German</language>
  <pages>83 S. : Ill., graph. Darst.</pages>
  <number/>
  <volume/>
  <abstract>A serious late effect in the dialsysis treatment is the dialysis associated amyloidosis as a result of accumulation of beta2-M in the serum. Aim of this study was to examine if the beta2-M concentration in blood can be reduced by dialysator-membranes with different permeability and adsorption capacity. For this purpose the following experiments have been carried out: 1. Determination of beta2-M-Clearance during dialysis with cuprophane- and PMMA-membranes. 2. Reduction of beta2-M-concentration in 9 different high-flux- and low-flux-membranes during a dialysis treatment. 3. Observation of beta2-M-concentration during one year of dialysis treatment using 4 different membrane-types at 10 patients each. The experiments show that neither the low-flux-membrane cuprophane nor the low-flux-membrane polysulfone are able to remove beta2-M from the serum of patients. Synthetic high-flux-membranes like polysulfone, polyamid and polymethylmethacrylat (PMMA) however are able to reduce the beta2-M-level during dialysis but without reaching normal results. Among these the PMMA-membrane possibly has the best effects because of its adsorptive capacity. This is demonstrated best in the long-term treatment. With this membrane a clearance of ca. 39ml/min can be reached. Although there is an elimination by synthetic membranes the predialytic concentration of beta2-M in blood is only little lower compared with non-eliminating membranes. Non of the examined membranes is able to normalize the concentration of beta2-M in serum. Because of the small number of cases and the short time of observation it is not possible to give evidence if by a minimal improvement of the elimination of beta2-M by synthetic high-flux-membranes the genesis of dialysis-associated amyloidosis is slowed down or prevented.</abstract>
  <notes>
    <note>Aachen, Techn. Hochsch., Diss., 2003 ; </note>
  </notes>
  <label>PUB:(DE-HGF)11, ; 2, ; </label>
  <keywords/>
  <accession-num/>
  <work-type>Dissertation / PhD Thesis</work-type>
  <dates>
    <pub-dates>
      <year>2003</year>
    </pub-dates>
  </dates>
  <accession-num>RWTH-CONV-121142</accession-num>
  <year>2003</year>
  <urls>
    <related-urls>
      <url>https://publications.rwth-aachen.de/record/59347</url>
    </related-urls>
  </urls>
</record>

</records>
</xml>